Published in Gene Therapy Weekly, January 13th, 2000
In their study appearing in the December 7, 1999, issue of Circulation, the team from the MGH Cardiovascular Research Center (CVRC), along with collaborators from Boston University Medical Center, Massachusetts, USA, and Imperial College in London, UK, reported delivering additional copies of a gene called SERCA2a to muscle cells from failing human hearts. Cells that incorporated the gene and produced elevated levels of its protein began to function...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.